世界の経口抗糖尿病剤市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Oral Antidiabetic Agents Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4620
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、経口抗糖尿病剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（スルホニル尿素剤、メグリチニド、ビグアニド、チアゾリジンジオン、α-グルコシダーゼ阻害剤）、用途別市場規模（家庭用、医療機関、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・経口抗糖尿病剤の市場動向
・企業の競争状況、市場シェア
・経口抗糖尿病剤の種類別市場規模と予測2016-2027（スルホニル尿素剤、メグリチニド、ビグアニド、チアゾリジンジオン、α-グルコシダーゼ阻害剤）
・経口抗糖尿病剤の用途別市場規模と予測2016-2027（家庭用、医療機関、その他）
・経口抗糖尿病剤の北米市場規模2016-2027（アメリカ、カナダ）
・経口抗糖尿病剤の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・経口抗糖尿病剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・経口抗糖尿病剤の中南米市場規模2016-2027（メキシコ、ブラジル）
・経口抗糖尿病剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Novo Nordisk、Eli Lilly、Sanofi、Roche、Teva、AstraZeneca、Wockhardt UK、Merck、Pfizer、Cipla）
・結論

Oral Antidiabetic Agents refer to the oral drugs used to treat type 2 diabetes in patients who uncontrolled by diet and exercise. Currently, there are five distinct classes of hypoglycemic agents available include sulfonylureas, meglitinides, biguanides, thiazolidinediones and alpha-glucosidase inhibitors.

Market Analysis and Insights: Global Oral Antidiabetic Agents Market
The global Oral Antidiabetic Agents market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oral Antidiabetic Agents market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oral Antidiabetic Agents market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oral Antidiabetic Agents market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oral Antidiabetic Agents market.

Global Oral Antidiabetic Agents Scope and Market Size
Oral Antidiabetic Agents market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oral Antidiabetic Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Sulfonylureas
Meglitinides
Biguanides
Thiazolidinediones
Alpha-glucosidase Inhibitors

Segment by Application
Home Use
Medical Institutions
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novo Nordisk
Eli Lilly
Sanofi
Roche
Teva
AstraZeneca
Wockhardt UK
Merck
Pfizer
Cipla

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Antidiabetic Agents Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Sulfonylureas
1.2.3 Meglitinides
1.2.4 Biguanides
1.2.5 Thiazolidinediones
1.2.6 Alpha-glucosidase Inhibitors
1.3 Market by Application
1.3.1 Global Oral Antidiabetic Agents Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Home Use
1.3.3 Medical Institutions
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Oral Antidiabetic Agents Market Perspective (2016-2027)
2.2 Oral Antidiabetic Agents Growth Trends by Regions
2.2.1 Oral Antidiabetic Agents Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Oral Antidiabetic Agents Historic Market Share by Regions (2016-2021)
2.2.3 Oral Antidiabetic Agents Forecasted Market Size by Regions (2022-2027)
2.3 Oral Antidiabetic Agents Industry Dynamic
2.3.1 Oral Antidiabetic Agents Market Trends
2.3.2 Oral Antidiabetic Agents Market Drivers
2.3.3 Oral Antidiabetic Agents Market Challenges
2.3.4 Oral Antidiabetic Agents Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Oral Antidiabetic Agents Players by Revenue
3.1.1 Global Top Oral Antidiabetic Agents Players by Revenue (2016-2021)
3.1.2 Global Oral Antidiabetic Agents Revenue Market Share by Players (2016-2021)
3.2 Global Oral Antidiabetic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oral Antidiabetic Agents Revenue
3.4 Global Oral Antidiabetic Agents Market Concentration Ratio
3.4.1 Global Oral Antidiabetic Agents Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Antidiabetic Agents Revenue in 2020
3.5 Oral Antidiabetic Agents Key Players Head office and Area Served
3.6 Key Players Oral Antidiabetic Agents Product Solution and Service
3.7 Date of Enter into Oral Antidiabetic Agents Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Oral Antidiabetic Agents Breakdown Data by Type
4.1 Global Oral Antidiabetic Agents Historic Market Size by Type (2016-2021)
4.2 Global Oral Antidiabetic Agents Forecasted Market Size by Type (2022-2027)

5 Oral Antidiabetic Agents Breakdown Data by Application
5.1 Global Oral Antidiabetic Agents Historic Market Size by Application (2016-2021)
5.2 Global Oral Antidiabetic Agents Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Oral Antidiabetic Agents Market Size (2016-2027)
6.2 North America Oral Antidiabetic Agents Market Size by Type
6.2.1 North America Oral Antidiabetic Agents Market Size by Type (2016-2021)
6.2.2 North America Oral Antidiabetic Agents Market Size by Type (2022-2027)
6.2.3 North America Oral Antidiabetic Agents Market Size by Type (2016-2027)
6.3 North America Oral Antidiabetic Agents Market Size by Application
6.3.1 North America Oral Antidiabetic Agents Market Size by Application (2016-2021)
6.3.2 North America Oral Antidiabetic Agents Market Size by Application (2022-2027)
6.3.3 North America Oral Antidiabetic Agents Market Size by Application (2016-2027)
6.4 North America Oral Antidiabetic Agents Market Size by Country
6.4.1 North America Oral Antidiabetic Agents Market Size by Country (2016-2021)
6.4.2 North America Oral Antidiabetic Agents Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Oral Antidiabetic Agents Market Size (2016-2027)
7.2 Europe Oral Antidiabetic Agents Market Size by Type
7.2.1 Europe Oral Antidiabetic Agents Market Size by Type (2016-2021)
7.2.2 Europe Oral Antidiabetic Agents Market Size by Type (2022-2027)
7.2.3 Europe Oral Antidiabetic Agents Market Size by Type (2016-2027)
7.3 Europe Oral Antidiabetic Agents Market Size by Application
7.3.1 Europe Oral Antidiabetic Agents Market Size by Application (2016-2021)
7.3.2 Europe Oral Antidiabetic Agents Market Size by Application (2022-2027)
7.3.3 Europe Oral Antidiabetic Agents Market Size by Application (2016-2027)
7.4 Europe Oral Antidiabetic Agents Market Size by Country
7.4.1 Europe Oral Antidiabetic Agents Market Size by Country (2016-2021)
7.4.2 Europe Oral Antidiabetic Agents Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Oral Antidiabetic Agents Market Size (2016-2027)
8.2 Asia-Pacific Oral Antidiabetic Agents Market Size by Type
8.2.1 Asia-Pacific Oral Antidiabetic Agents Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Oral Antidiabetic Agents Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Oral Antidiabetic Agents Market Size by Type (2016-2027)
8.3 Asia-Pacific Oral Antidiabetic Agents Market Size by Application
8.3.1 Asia-Pacific Oral Antidiabetic Agents Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Oral Antidiabetic Agents Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Oral Antidiabetic Agents Market Size by Application (2016-2027)
8.4 Asia-Pacific Oral Antidiabetic Agents Market Size by Region
8.4.1 Asia-Pacific Oral Antidiabetic Agents Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Oral Antidiabetic Agents Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Oral Antidiabetic Agents Market Size (2016-2027)
9.2 Latin America Oral Antidiabetic Agents Market Size by Type
9.2.1 Latin America Oral Antidiabetic Agents Market Size by Type (2016-2021)
9.2.2 Latin America Oral Antidiabetic Agents Market Size by Type (2022-2027)
9.2.3 Latin America Oral Antidiabetic Agents Market Size by Type (2016-2027)
9.3 Latin America Oral Antidiabetic Agents Market Size by Application
9.3.1 Latin America Oral Antidiabetic Agents Market Size by Application (2016-2021)
9.3.2 Latin America Oral Antidiabetic Agents Market Size by Application (2022-2027)
9.3.3 Latin America Oral Antidiabetic Agents Market Size by Application (2016-2027)
9.4 Latin America Oral Antidiabetic Agents Market Size by Country
9.4.1 Latin America Oral Antidiabetic Agents Market Size by Country (2016-2021)
9.4.2 Latin America Oral Antidiabetic Agents Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Oral Antidiabetic Agents Market Size (2016-2027)
10.2 Middle East & Africa Oral Antidiabetic Agents Market Size by Type
10.2.1 Middle East & Africa Oral Antidiabetic Agents Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Oral Antidiabetic Agents Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Oral Antidiabetic Agents Market Size by Type (2016-2027)
10.3 Middle East & Africa Oral Antidiabetic Agents Market Size by Application
10.3.1 Middle East & Africa Oral Antidiabetic Agents Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Oral Antidiabetic Agents Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Oral Antidiabetic Agents Market Size by Application (2016-2027)
10.4 Middle East & Africa Oral Antidiabetic Agents Market Size by Country
10.4.1 Middle East & Africa Oral Antidiabetic Agents Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Oral Antidiabetic Agents Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Details
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Oral Antidiabetic Agents Introduction
11.1.4 Novo Nordisk Revenue in Oral Antidiabetic Agents Business (2016-2021)
11.1.5 Novo Nordisk Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Oral Antidiabetic Agents Introduction
11.2.4 Eli Lilly Revenue in Oral Antidiabetic Agents Business (2016-2021)
11.2.5 Eli Lilly Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Oral Antidiabetic Agents Introduction
11.3.4 Sanofi Revenue in Oral Antidiabetic Agents Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Oral Antidiabetic Agents Introduction
11.4.4 Roche Revenue in Oral Antidiabetic Agents Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Teva
11.5.1 Teva Company Details
11.5.2 Teva Business Overview
11.5.3 Teva Oral Antidiabetic Agents Introduction
11.5.4 Teva Revenue in Oral Antidiabetic Agents Business (2016-2021)
11.5.5 Teva Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Oral Antidiabetic Agents Introduction
11.6.4 AstraZeneca Revenue in Oral Antidiabetic Agents Business (2016-2021)
11.6.5 AstraZeneca Recent Development
11.7 Wockhardt UK
11.7.1 Wockhardt UK Company Details
11.7.2 Wockhardt UK Business Overview
11.7.3 Wockhardt UK Oral Antidiabetic Agents Introduction
11.7.4 Wockhardt UK Revenue in Oral Antidiabetic Agents Business (2016-2021)
11.7.5 Wockhardt UK Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Oral Antidiabetic Agents Introduction
11.8.4 Merck Revenue in Oral Antidiabetic Agents Business (2016-2021)
11.8.5 Merck Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Oral Antidiabetic Agents Introduction
11.9.4 Pfizer Revenue in Oral Antidiabetic Agents Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Cipla
11.10.1 Cipla Company Details
11.10.2 Cipla Business Overview
11.10.3 Cipla Oral Antidiabetic Agents Introduction
11.10.4 Cipla Revenue in Oral Antidiabetic Agents Business (2016-2021)
11.10.5 Cipla Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Oral Antidiabetic Agents Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Sulfonylureas
Table 3. Key Players of Meglitinides
Table 4. Key Players of Biguanides
Table 5. Key Players of Thiazolidinediones
Table 6. Key Players of Alpha-glucosidase Inhibitors
Table 7. Global Oral Antidiabetic Agents Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Oral Antidiabetic Agents Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Oral Antidiabetic Agents Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Oral Antidiabetic Agents Market Share by Regions (2016-2021)
Table 11. Global Oral Antidiabetic Agents Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Oral Antidiabetic Agents Market Share by Regions (2022-2027)
Table 13. Oral Antidiabetic Agents Market Trends
Table 14. Oral Antidiabetic Agents Market Drivers
Table 15. Oral Antidiabetic Agents Market Challenges
Table 16. Oral Antidiabetic Agents Market Restraints
Table 17. Global Oral Antidiabetic Agents Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Oral Antidiabetic Agents Market Share by Players (2016-2021)
Table 19. Global Top Oral Antidiabetic Agents Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Antidiabetic Agents as of 2020)
Table 20. Ranking of Global Top Oral Antidiabetic Agents Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Oral Antidiabetic Agents Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Oral Antidiabetic Agents Product Solution and Service
Table 24. Date of Enter into Oral Antidiabetic Agents Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oral Antidiabetic Agents Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Oral Antidiabetic Agents Revenue Market Share by Type (2016-2021)
Table 28. Global Oral Antidiabetic Agents Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Oral Antidiabetic Agents Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Oral Antidiabetic Agents Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Oral Antidiabetic Agents Revenue Market Share by Application (2016-2021)
Table 32. Global Oral Antidiabetic Agents Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Oral Antidiabetic Agents Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Oral Antidiabetic Agents Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Oral Antidiabetic Agents Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Oral Antidiabetic Agents Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Oral Antidiabetic Agents Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Oral Antidiabetic Agents Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Oral Antidiabetic Agents Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Oral Antidiabetic Agents Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Oral Antidiabetic Agents Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Oral Antidiabetic Agents Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Oral Antidiabetic Agents Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Oral Antidiabetic Agents Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Oral Antidiabetic Agents Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Oral Antidiabetic Agents Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Oral Antidiabetic Agents Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Oral Antidiabetic Agents Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Oral Antidiabetic Agents Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Oral Antidiabetic Agents Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Oral Antidiabetic Agents Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Oral Antidiabetic Agents Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Oral Antidiabetic Agents Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Oral Antidiabetic Agents Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Oral Antidiabetic Agents Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Oral Antidiabetic Agents Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Oral Antidiabetic Agents Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Oral Antidiabetic Agents Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Oral Antidiabetic Agents Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Oral Antidiabetic Agents Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Oral Antidiabetic Agents Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Oral Antidiabetic Agents Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Oral Antidiabetic Agents Market Size by Country (2022-2027) & (US$ Million)
Table 64. Novo Nordisk Company Details
Table 65. Novo Nordisk Business Overview
Table 66. Novo Nordisk Oral Antidiabetic Agents Product
Table 67. Novo Nordisk Revenue in Oral Antidiabetic Agents Business (2016-2021) & (US$ Million)
Table 68. Novo Nordisk Recent Development
Table 69. Eli Lilly Company Details
Table 70. Eli Lilly Business Overview
Table 71. Eli Lilly Oral Antidiabetic Agents Product
Table 72. Eli Lilly Revenue in Oral Antidiabetic Agents Business (2016-2021) & (US$ Million)
Table 73. Eli Lilly Recent Development
Table 74. Sanofi Company Details
Table 75. Sanofi Business Overview
Table 76. Sanofi Oral Antidiabetic Agents Product
Table 77. Sanofi Revenue in Oral Antidiabetic Agents Business (2016-2021) & (US$ Million)
Table 78. Sanofi Recent Development
Table 79. Roche Company Details
Table 80. Roche Business Overview
Table 81. Roche Oral Antidiabetic Agents Product
Table 82. Roche Revenue in Oral Antidiabetic Agents Business (2016-2021) & (US$ Million)
Table 83. Roche Recent Development
Table 84. Teva Company Details
Table 85. Teva Business Overview
Table 86. Teva Oral Antidiabetic Agents Product
Table 87. Teva Revenue in Oral Antidiabetic Agents Business (2016-2021) & (US$ Million)
Table 88. Teva Recent Development
Table 89. AstraZeneca Company Details
Table 90. AstraZeneca Business Overview
Table 91. AstraZeneca Oral Antidiabetic Agents Product
Table 92. AstraZeneca Revenue in Oral Antidiabetic Agents Business (2016-2021) & (US$ Million)
Table 93. AstraZeneca Recent Development
Table 94. Wockhardt UK Company Details
Table 95. Wockhardt UK Business Overview
Table 96. Wockhardt UK Oral Antidiabetic Agents Product
Table 97. Wockhardt UK Revenue in Oral Antidiabetic Agents Business (2016-2021) & (US$ Million)
Table 98. Wockhardt UK Recent Development
Table 99. Merck Company Details
Table 100. Merck Business Overview
Table 101. Merck Revenue in Oral Antidiabetic Agents Business (2016-2021) & (US$ Million)
Table 102. Merck Recent Development
Table 103. Pfizer Company Details
Table 104. Pfizer Business Overview
Table 105. Pfizer Oral Antidiabetic Agents Product
Table 106. Pfizer Revenue in Oral Antidiabetic Agents Business (2016-2021) & (US$ Million)
Table 107. Pfizer Recent Development
Table 108. Cipla Company Details
Table 109. Cipla Business Overview
Table 110. Cipla Oral Antidiabetic Agents Product
Table 111. Cipla Revenue in Oral Antidiabetic Agents Business (2016-2021) & (US$ Million)
Table 112. Cipla Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Antidiabetic Agents Market Share by Type: 2020 VS 2027
Figure 2. Sulfonylureas Features
Figure 3. Meglitinides Features
Figure 4. Biguanides Features
Figure 5. Thiazolidinediones Features
Figure 6. Alpha-glucosidase Inhibitors Features
Figure 7. Global Oral Antidiabetic Agents Market Share by Application: 2020 VS 2027
Figure 8. Home Use Case Studies
Figure 9. Medical Institutions Case Studies
Figure 10. Others Case Studies
Figure 11. Oral Antidiabetic Agents Report Years Considered
Figure 12. Global Oral Antidiabetic Agents Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Oral Antidiabetic Agents Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Oral Antidiabetic Agents Market Share by Regions: 2020 VS 2027
Figure 15. Global Oral Antidiabetic Agents Market Share by Regions (2022-2027)
Figure 16. Global Oral Antidiabetic Agents Market Share by Players in 2020
Figure 17. Global Top Oral Antidiabetic Agents Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Antidiabetic Agents as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Oral Antidiabetic Agents Revenue in 2020
Figure 19. Global Oral Antidiabetic Agents Revenue Market Share by Type (2016-2021)
Figure 20. Global Oral Antidiabetic Agents Revenue Market Share by Type (2022-2027)
Figure 21. North America Oral Antidiabetic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Oral Antidiabetic Agents Market Share by Type (2016-2027)
Figure 23. North America Oral Antidiabetic Agents Market Share by Application (2016-2027)
Figure 24. North America Oral Antidiabetic Agents Market Share by Country (2016-2027)
Figure 25. United States Oral Antidiabetic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Oral Antidiabetic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Oral Antidiabetic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Oral Antidiabetic Agents Market Share by Type (2016-2027)
Figure 29. Europe Oral Antidiabetic Agents Market Share by Application (2016-2027)
Figure 30. Europe Oral Antidiabetic Agents Market Share by Country (2016-2027)
Figure 31. Germany Oral Antidiabetic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Oral Antidiabetic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Oral Antidiabetic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Oral Antidiabetic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Oral Antidiabetic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Oral Antidiabetic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Oral Antidiabetic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Oral Antidiabetic Agents Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Oral Antidiabetic Agents Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Oral Antidiabetic Agents Market Share by Region (2016-2027)
Figure 41. China Oral Antidiabetic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Oral Antidiabetic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Oral Antidiabetic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Oral Antidiabetic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Oral Antidiabetic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Oral Antidiabetic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Oral Antidiabetic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Oral Antidiabetic Agents Market Share by Type (2016-2027)
Figure 49. Latin America Oral Antidiabetic Agents Market Share by Application (2016-2027)
Figure 50. Latin America Oral Antidiabetic Agents Market Share by Country (2016-2027)
Figure 51. Mexico Oral Antidiabetic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Oral Antidiabetic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Oral Antidiabetic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Oral Antidiabetic Agents Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Oral Antidiabetic Agents Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Oral Antidiabetic Agents Market Share by Country (2016-2027)
Figure 57. Turkey Oral Antidiabetic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Oral Antidiabetic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Oral Antidiabetic Agents Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Novo Nordisk Revenue Growth Rate in Oral Antidiabetic Agents Business (2016-2021)
Figure 61. Eli Lilly Revenue Growth Rate in Oral Antidiabetic Agents Business (2016-2021)
Figure 62. Sanofi Revenue Growth Rate in Oral Antidiabetic Agents Business (2016-2021)
Figure 63. Roche Revenue Growth Rate in Oral Antidiabetic Agents Business (2016-2021)
Figure 64. Teva Revenue Growth Rate in Oral Antidiabetic Agents Business (2016-2021)
Figure 65. AstraZeneca Revenue Growth Rate in Oral Antidiabetic Agents Business (2016-2021)
Figure 66. Wockhardt UK Revenue Growth Rate in Oral Antidiabetic Agents Business (2016-2021)
Figure 67. Merck Revenue Growth Rate in Oral Antidiabetic Agents Business (2016-2021)
Figure 68. Pfizer Revenue Growth Rate in Oral Antidiabetic Agents Business (2016-2021)
Figure 69. Cipla Revenue Growth Rate in Oral Antidiabetic Agents Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

以下、関連資料のご紹介

世界の経口血糖降下薬市場規模・現状・予測（2021年-2027年）

Global Oral Hypoglycemic Agents Market Size, Status and Forecast 2021-2027
QFJ1-5913 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、経口血糖降下薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（液体、カプセル、錠剤）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界の口腔がん分子診断市場規模・現状・予測（2021年-2027年）

Global Oral Cancer Molecular Diagnosis Market Size, Status and Forecast 2021-2027
QFJ1-4622 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、口腔がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の組織シーリング剤＆止血市場規模・現状・予測（2021年-2027年）

Global Tissue Sealing Agents and Hemostasis Market Size, Status and Forecast 2021-2027
QFJ1-5363 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、組織シーリング剤＆止血の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（天然組織シーラント、合成組織シーラント、その他）、用途別市場規模（学術、病院、研究所、その他）、主要地域別市場規模（北米、アメリカ...

世界の抗腫瘍薬市場規模・現状・予測（2021年-2027年）

Global Anti-Neoplastic Pharmaceutical Agents Market Size, Status and Forecast 2021-2027
QFJ1-3830 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、抗腫瘍薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ホルモン＆拮抗薬、微生物製品、植物製品、抗腫瘍抗生物質、アルキル化剤、代謝拮抗剤、天然物）、用途別市場規模（肺がん、膀胱がん、乳がん、子宮頸がん...

世界の経口免疫賦活剤市場規模・現状・予測（2021年-2027年）

Global Oral Immunostimulant Market Size, Status and Forecast 2021-2027
QFJ1-5914 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、経口免疫賦活剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（インターロイキン、グルカン、リポ多糖、レバミゾール、イソプリノシン）、用途別市場規模（病院薬局、小売薬局、ドラッグストア、オンライン薬局）...

世界の経口高分子製剤市場規模・現状・予測（2021年-2027年）

Global Oral Macromolecule Formulation Market Size, Status and Forecast 2021-2027
QFJ1-5915 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、経口高分子製剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カプセル、錠剤、液体）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界の口腔ケア＆口腔衛生市場規模・現状・予測（2021年-2027年）

Global Oral Care and Oral Hygiene Market Size, Status and Forecast 2021-2027
QFJ1-4623 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、口腔ケア＆口腔衛生の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（歯磨き粉、歯ブラシ、うがい薬、歯科用アクセサリー、義歯製品、歯科補綴物洗浄剤）、用途別市場規模（消費者向け店舗、小売薬局、オンライン配...

世界のオーラルリンス市場規模・現状・予測（2021年-2027年）

Global Oral Rinse Market Size, Status and Forecast 2021-2027
QFJ1-4624 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、オーラルリンスの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（防腐剤、鎮痛剤、抗真菌剤、抗炎症剤）、用途別市場規模（オンライン薬局、ドラッグストア、歯科医院、小売薬局）、主要地域別市場規模（北米、アメ...

世界の栄養補助食品用経口薄膜市場規模・現状・予測（2021年-2027年）

Global Nutraceutical Oral Thin Films Market Size, Status and Forecast 2021-2027
QFJ1-4600 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、栄養補助食品用経口薄膜の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（酸化防止剤、多価不飽和脂肪酸、プレバイオティクス、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域...

世界の口腔がん診断市場規模・現状・予測（2021年-2027年）

Global Oral Cancer Diagnosis Market Size, Status and Forecast 2021-2027
QFJ1-4621 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、口腔がん診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（コンピュータ断層撮影（CT）スキャン、磁気共鳴画像（MRI）、ポジトロン放出断層撮影（PET）、超音波検査、生検、X線、内視鏡検査、蛍光画像...

世界の経口血糖降下薬市場規模・現状・予測（2021年-2027年） The drugs can treat diabetic by reducing glucose concentrations. The drugs can treat diabete by reducing glucose concentrations. These drugs mainly focus on the Type 2 diabetes. Oral drugs can control the glucose by stimulating the islet cells. Market Analysis and Insights: Global Oral Hypoglycemic …
世界の組織シーリング剤＆止血市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tissue Sealing Agents and Hemostasis Market The global Tissue Sealing Agents and Hemostasis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and h…
世界の口腔がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing oral cancer Market Analysis and Insights: Global Oral Cancer Molecular Diagnosis Market The global Oral Cancer Molecular Diagnosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With indust…
世界の抗腫瘍薬市場規模・現状・予測（2021年-2027年） Anti-neoplastic are the drugs that prevent growth of any abnormal tissue leading to cancer. The drugs pass into the human body and destroy cancerous cells. These drugs are also used in conjunction with surgery, radiotherapy and immunotherapy for solid tumors. The anti-neoplastic pharmaceutical agent…
世界の経口免疫賦活剤市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Oral Immunostimulant Market The global Oral Immunostimulant market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report m…